DE602007011739D1 - Verwendung von cholest-4-en-3-on-derivaten zur erhaltung eines zytoprotektiven medikaments - Google Patents

Verwendung von cholest-4-en-3-on-derivaten zur erhaltung eines zytoprotektiven medikaments

Info

Publication number
DE602007011739D1
DE602007011739D1 DE602007011739T DE602007011739T DE602007011739D1 DE 602007011739 D1 DE602007011739 D1 DE 602007011739D1 DE 602007011739 T DE602007011739 T DE 602007011739T DE 602007011739 T DE602007011739 T DE 602007011739T DE 602007011739 D1 DE602007011739 D1 DE 602007011739D1
Authority
DE
Germany
Prior art keywords
gen
cholest
carbon
image
cytoprotective
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602007011739T
Other languages
German (de)
English (en)
Inventor
Rebecca Pruss
Bruno Buisson
Thierry Bordet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Trophos SA
Original Assignee
Trophos SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Trophos SA filed Critical Trophos SA
Publication of DE602007011739D1 publication Critical patent/DE602007011739D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
DE602007011739T 2006-03-31 2007-03-28 Verwendung von cholest-4-en-3-on-derivaten zur erhaltung eines zytoprotektiven medikaments Active DE602007011739D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0602799A FR2899108B1 (fr) 2006-03-31 2006-03-31 Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur
PCT/FR2007/000530 WO2007118967A1 (fr) 2006-03-31 2007-03-28 Utilisation de derives du cholest-4-en-3-one pour l'obtention d'un medicament cytoprotecteur

Publications (1)

Publication Number Publication Date
DE602007011739D1 true DE602007011739D1 (de) 2011-02-17

Family

ID=36954506

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602007011739T Active DE602007011739D1 (de) 2006-03-31 2007-03-28 Verwendung von cholest-4-en-3-on-derivaten zur erhaltung eines zytoprotektiven medikaments

Country Status (18)

Country Link
US (1) US9320745B2 (es)
EP (1) EP2001483B1 (es)
JP (2) JP5662020B2 (es)
KR (1) KR101409027B1 (es)
CN (1) CN101443019B (es)
AT (1) ATE493989T1 (es)
AU (1) AU2007239395B2 (es)
BR (1) BRPI0709925A8 (es)
CA (1) CA2647501C (es)
DE (1) DE602007011739D1 (es)
DK (1) DK2001483T3 (es)
ES (1) ES2359173T3 (es)
FR (1) FR2899108B1 (es)
HK (1) HK1129841A1 (es)
IL (1) IL194293A0 (es)
MX (1) MX2008012611A (es)
RU (1) RU2428189C2 (es)
WO (1) WO2007118967A1 (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2874923B1 (fr) * 2004-09-07 2006-10-27 Trophos Sa Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation
FR2919180B1 (fr) * 2007-07-25 2009-11-27 Trophos Utilisation d'au moins un derive oxime de la cholest-4-en-3-one comme antioxydants
AU2008348717B2 (en) * 2007-10-30 2013-09-19 Trophos Novel composition for treating the side effects of anticancer treatments
WO2012069150A2 (en) 2010-11-22 2012-05-31 Powerpore Gmbh Cytoprotectant agents for the prevention of drug-associated side-effects
FR2979239A1 (fr) 2011-08-25 2013-03-01 Trophos Liposome comprenant au moins un derive de cholesterol
TWI638815B (zh) 2013-02-15 2018-10-21 英商葛蘭素史克智慧財產發展有限公司 作為激酶抑制劑之雜環醯胺類（一）
RU2629772C1 (ru) * 2016-05-31 2017-09-04 Федеральное государственное бюджетное учреждение науки Тихоокеанский институт биоорганической химии им. Г.Б. Елякова Дальневосточного отделения Российской академии наук (ТИБОХ ДВО РАН) Кардиопротекторная фармацевтическая субстанция и способ ее получения
CN107746423B (zh) * 2017-09-07 2020-02-14 佛山科学技术学院 麦角甾-7，22-二烯-3-酮肟及其制备方法和在制备抗菌药物中的应用
CN115040524A (zh) * 2022-07-27 2022-09-13 深圳市中西医结合医院 4-胆甾烯-3-酮用于治疗多发性骨髓瘤骨病的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3186365B2 (ja) * 1993-09-02 2001-07-11 日本油脂株式会社 肝疾患治療薬
JP3129367B2 (ja) * 1993-10-08 2001-01-29 日本油脂株式会社 角化亢進抑制剤
PT1601363E (pt) * 2003-03-11 2012-08-17 Trophos Aplicação como medicamentos de derivados da colest-4-en-3- ona, composições farmacêuticas que os contêm e novos derivados
EP1618881A1 (en) * 2004-07-20 2006-01-25 Santhera Pharmaceuticals (Schweiz) GmbH Use of non-glucocorticoid steroids for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
RU2008143248A (ru) 2010-05-10
AU2007239395A1 (en) 2007-10-25
ES2359173T3 (es) 2011-05-19
FR2899108A1 (fr) 2007-10-05
BRPI0709925A2 (pt) 2011-08-02
JP2014051525A (ja) 2014-03-20
FR2899108B1 (fr) 2012-02-03
DK2001483T3 (da) 2011-04-18
US9320745B2 (en) 2016-04-26
IL194293A0 (en) 2009-09-22
JP5662020B2 (ja) 2015-01-28
CN101443019A (zh) 2009-05-27
EP2001483B1 (fr) 2011-01-05
KR101409027B1 (ko) 2014-06-18
JP2009531397A (ja) 2009-09-03
WO2007118967A1 (fr) 2007-10-25
EP2001483A1 (fr) 2008-12-17
HK1129841A1 (en) 2009-12-11
CN101443019B (zh) 2013-07-17
RU2428189C2 (ru) 2011-09-10
ATE493989T1 (de) 2011-01-15
MX2008012611A (es) 2008-10-31
KR20090016549A (ko) 2009-02-16
AU2007239395B2 (en) 2012-05-24
CA2647501A1 (fr) 2007-10-25
CA2647501C (fr) 2013-10-08
BRPI0709925A8 (pt) 2018-04-24
US20090186863A1 (en) 2009-07-23

Similar Documents

Publication Publication Date Title
DE602007011739D1 (de) Verwendung von cholest-4-en-3-on-derivaten zur erhaltung eines zytoprotektiven medikaments
UY30301A1 (es) Ácidos bifenilcarboxílicos substituidos y sus derivados
UY30300A1 (es) Compuestos triarílicos y sus derivados
TNSN07148A1 (en) (biphenyl) carboxylic acids and derivatives thereof
EA201001595A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
NO20052167L (no) Hjelpemidler eller preventivmidler mot urineringsfrekvens eller urinkontinens og morfinanderivater med nitrogenholdig heterocyklisk gruppe
WO2007127635A3 (en) Diketo-piperazine and piperidine derivatives as antiviral agents
TW200745070A (en) Novel 1,4-benzothiazepine 1,1-dioxide derivative with improved properties, process for its preparation, medicaments comprising this compound and their use
TW200602031A (en) Antiinflammatory and pain-relieving agent for external, use
DE602004005502D1 (de) Comt-inhibitoren
WO2007010294A3 (en) Use of delmopinol in the treatment of acne
ATE492534T1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate
UY27959A1 (es) Nuevos agonistas ppar alfa y ppar gama
NO20060277L (no) Anvendelse av bisyklo [2.2.1] heptanderivater til fremstilling av nevrobeskyttende farmasoytiske sammensetninger
BR0209735A (pt) Derivados heterocìclicos e uso medicinal destes
WO2009016081A3 (en) Benzoind0l-2-one derivatives for use in therapy
ATE487685T1 (de) (-)-stereoisomer von 2,6-di-sec-butylphenol und analoga davon
ATE432262T1 (de) Pyrazolphenylderivate als ppar-aktivatoren
DE602005017581D1 (de) Verwendung von substituierten 1,2,3-indolizin-derivaten zur behandlung von krankheiten im zusammenhang mit einer pathologischen angiogenese
DE602005016534D1 (de) Medikament zur prävention oder behandlung von häufigem harndrang oder harninkontinenz
YU94003A (sh) Novo heterociklično jedinjenje i njegova medicinska upotreba
ATE511506T1 (de) Thiopen-derivate als wirkstoffe gegen okulare hypotonie
BRPI0513083A (pt) oxazolidinonas contendo oxindóis como agentes antibacterianos
UA96775C2 (en) Process for the preparation of pleuromutilins
AR063924A1 (es) Analogos de pirazol